ORCL - NVDA ORCL among premarket gainers September, 14 2020 08:39 AM Oracle Corporation Immunomedics (NASDAQ:IMMU) +106% after Gilead to buy the company for $21B (~$88/share).More news on: Immunomedics, Inc., Cassava Sciences, Inc., China Natural Resources, Inc., , Stocks on the move, Read more ...